These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 37507074)
1. Germline Determinants of Esophageal Adenocarcinoma. Lee M; Eng G; Handte-Reinecker A; ; Deshpande VS; Yilmaz OH; Gala MK Gastroenterology; 2023 Nov; 165(5):1276-1279.e7. PubMed ID: 37507074 [No Abstract] [Full Text] [Related]
2. Targeted Single Gene Mutation in Esophageal Adenocarcinoma. Lee KTW; Smith RA; Gopalan V; Lam AK Methods Mol Biol; 2018; 1756():213-229. PubMed ID: 29600373 [TBL] [Abstract][Full Text] [Related]
3. Detection and Quantification of MicroRNAs in Esophageal Adenocarcinoma. Amin M; Islam F; Gopalan V; Lam AK Methods Mol Biol; 2018; 1756():257-268. PubMed ID: 29600376 [TBL] [Abstract][Full Text] [Related]
4. [Adenocarcinoma arising in gastroesophageal junction: a reappraisal]. Zhang XH Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):363-5. PubMed ID: 17822618 [No Abstract] [Full Text] [Related]
5. Tumor microRNA-126 controls cell viability and associates with poor survival in patients with esophageal adenocarcinoma. Toxopeus E; Lynam-Lennon N; Biermann K; Dickens G; de Ruiter PE; van Lanschot J; Reynolds JV; Wijnhoven B; O'Sullivan J; van der Laan L Exp Biol Med (Maywood); 2019 Oct; 244(14):1210-1219. PubMed ID: 31390899 [TBL] [Abstract][Full Text] [Related]
6. DNA Genome Sequencing in Esophageal Adenocarcinoma. Pillai S; Gopalan V; Lam AK Methods Mol Biol; 2018; 1756():231-246. PubMed ID: 29600374 [TBL] [Abstract][Full Text] [Related]
7. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations. Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686 [TBL] [Abstract][Full Text] [Related]
8. Genetic Defect in Submucosal Gland-Associated Caveolin-3: A New Paradigm in Esophageal Adenocarcinoma Risk. Garman KS; Purkayastha BPD; Hogue JA; Fecteau R; ; Guda K; Chak A Gastroenterology; 2023 Dec; 165(6):1561-1564.e3. PubMed ID: 37659676 [No Abstract] [Full Text] [Related]
19. Vacutainers and Primers Over X-Rays and Gamma Rays: The Role of Circulating Tumor DNA in Esophageal Adenocarcinoma Staging and Surveillance: Invited Commentary on "Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma". Chandra R; Reznik SI Ann Surg; 2022 Aug; 276(2):e127-e128. PubMed ID: 36036995 [No Abstract] [Full Text] [Related]
20. Neoplastic risk assessment in Barrett's esophagus: How far have we come? Noffsinger A Hum Pathol; 2003 Oct; 34(10):965-7. PubMed ID: 14608528 [No Abstract] [Full Text] [Related] [Next] [New Search]